RBM39 and liver cancer: It pointed out that anti-RBM39 autoantibody was the highest in liver cancer, and its immunostaining intensity in liver cancer cells was significantly reduced, and it was positively correlated with its decreased expression level, which further indicated that the decrease in RBM39 expression level might be related to the appearance of microvessels [45].